News

All Releases
Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology
Dec 14, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,833,177 titled "Insulin Pump Based Expert System." This patent
Tandem Diabetes Care Announces Retirement of CFO and Successor Appointment
Dec 07, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced the retirement of its executive vice president and chief financial officer (CFO), John Cajigas , effective December 31, 2017 . Leigh Vosseller , who is currently serving at Tandem's senior vice president of
Tandem Diabetes Care to Present at the 29th Annual Piper Jaffray Healthcare Conference
Nov 16, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the 29 th Annual
Tandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference
Nov 07, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the Stifel 2017
Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump with Automated Insulin Delivery Feature
Nov 02, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today presented results from a Human Factors study conducted to validate the safety of the user interface of a
Tandem Diabetes Care Reports Third Quarter 2017 Financial Results
Oct 26, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended September 30, 2017 .
Tandem Diabetes Care to Provide All t:slim X2 Insulin Pump Features Approved in 2018 to Users at No Cost and Expands Existing Dexcom Welcome Offer for Animas Customers
Oct 24, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it will make any new features approved for the t:slim X2™ Insulin Pump by the U.S.
Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call
Oct 16, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its third quarter 2017 results after the financial markets close on Thursday, October 26, 2017
Tandem Diabetes Care Announces Pricing of $16.2 Million Underwritten Public Offering of Common Stock and Warrants
Oct 13, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the pricing of an underwritten public offering of (i) 4,630,000 shares of its common stock, (ii)
Tandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock, Series A Warrants and Series B Warrants
Oct 12, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that it is proposing to offer and sell shares of its common stock, Series A warrants and Series
Tandem Diabetes Care Announces Approval of Reverse Stock Split
Oct 09, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) previously announced that a proposal was approved at its Special Meeting of Stockholders, held September 7, 2017 , authorizing its Board of Directors to amend the Company's certificate of incorporation to effect a reverse
Tandem Diabetes Care Reports Rapid Uptake and High Satisfaction Scores For t:slim X2 Insulin Pump Remote Software Update Following Launch of CGM Integration
Sep 28, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that one-third of t:slim X2™ Pump users have already updated their pumps via personal computer
Tandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
Aug 28, 2017
‒ Software Update Available for Current t:slim X2 Pump Users Via Personal Computer ‒ SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced U.S.
Tandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps
Aug 24, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,737,656 titled "Integration of Infusion Pump with Remote
Tandem Diabetes Care Announces Launch of t:lock Connector for its Insulin Pump Cartridges and Infusion Sets
Aug 23, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the launch of the t:lock™ Connector for its insulin pump cartridges and infusion sets.
Tandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with Predictive Low Glucose Suspend (PLGS)
Aug 15, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced enrollment of the first patients in an at-home pivotal trial for its t:slim X2™ Insulin Pump
Tandem Diabetes Care Announces Issuance of Patent Related to Important Safety Features for Portable Infusion Pumps that Utilize Touchscreen Control
Aug 08, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced the issuance of U.S. Patent No. 9,715,327 titled "Preventing Inadvertent Changes in Ambulatory
Tandem Diabetes Care to Present at the 2017 Wedbush PacGrow Healthcare Conference
Aug 01, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today announced that Kim Blickenstaff , president and CEO, will present a company update at the 2017 Wedbush
Tandem Diabetes Care Reports Second Quarter 2017 Financial Results
Jul 27, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , today reported its financial results for the quarter ended June 30, 2017 .
Tandem Diabetes Care Schedules Second Quarter 2017 Earnings Press Release and Conference Call
Jul 13, 2017
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States , plans to release its second quarter 2017 results after the financial markets close on Thursday, July 27, 2017 .
Displaying 21 - 40 of 152